In June 2024, Yugmedpharm received a license to manufacture medicines for clinical trials (tests). License registration number: L012-00102-77/01247351.
The document was issued by the Ministry of Industry and Trade of Russia following an on-site inspection by the department’s specialists. Thus, the company was given permission to start manufacturing medicines. The production is focused on the release of domestic solid non-sterile dosage forms in capsules, tablets, powders and granules.
The production is planned to be carried out in two production buildings, at four production sites. The first two sites are already equipped with technological and auxiliary equipment. There is an in-house chemical analytical laboratory. The annual production capacity of the enterprise at the launch stage of the first stage is designed to manufacture 125 million packages of medicines.